Filing Details

Accession Number:
0001179110-14-008265
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-13 12:47:50
Reporting Period:
2014-05-12
Filing Date:
2014-05-13
Accepted Time:
2014-05-13 12:47:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288288 J Brian Smith C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Svp And Special Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-12 40,000 $39.97 92,635 No 4 M Direct
Commonstock Disposition 2014-05-12 18,000 $48.00 74,635 No 4 S Direct
Common Stock Disposition 2014-05-12 100 $48.00 74,535 No 4 S Direct
Common Stock Disposition 2014-05-12 15,000 $48.01 59,535 No 4 S Direct
Common Stock Disposition 2014-05-12 100 $48.01 59,435 No 4 S Direct
Common Stock Disposition 2014-05-12 6,400 $48.01 53,035 No 4 S Direct
Common Stock Disposition 2014-05-12 200 $48.02 52,835 No 4 S Direct
Common Stock Disposition 2014-05-12 100 $48.02 52,735 No 4 S Direct
Common Stock Disposition 2014-05-12 100 $48.03 52,635 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Acquisiton 2014-05-12 40,000 $0.00 40,000 $39.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,707 Indirect See note 4.
Footnotes
  1. The stock options, granted on May 15, 2007, vested in three equal installments on May 15, 2008, 2009, and 2010. The exercise price of $39.970 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
  2. Exercise of derivative security exempted pursuant to Rule 16b-3.
  3. Multiple lots for the same price for this order have been combined.
  4. Balance in the qualified Hospira 401(k) Retirement Savings Plan, as of May 12, 2014.